17Aug
UK Life Sciences and Healthcare Newsletter - August 2020: COVID-19 – How Have Listed Companies Fared?
COVID-19 has had a significant financial impact on many listed companies and, in recent months, there has been a marked increase in equity capital raises by listed companies. As at 22 July 2020, there have been over 100 secondary equity fundraisings in excess of £10 million on the Main Market and AIM since the COVID lockdown period began. Some have had to raise emergency capital, on short notice and often at significant discounts, whereas others have sought to shore up their balance sheets as...
By:
Dechert LLP
Source Url: https://www.jdsupra.com/legalnews/uk-life-sciences-and-healthcare-82301/
Related
The Federal Trade Commission and the U.S. Department of Justice this week announced the final versio...
Read More >
Last May OSHA began enforcing various provisions of the agency’s requirements of the beryllium stan...
Read More >
This edition of Employment Flash looks at recent NLRB activity, including its decision (overruling a...
Read More >
Part 2: New Employment-Related Court Decisions Impacting California’s Public and Private Entities -...
Read More >
In a highly unfavorable peer review decision, Leadbitter v. Keystone Anesthesia v. Petraglia, entere...
Read More >
In this episode of Trekking Through Compliance, we consider the episode Metamorphosis which aired on...
Read More >